In a subgroup of high-risk asians, telmisartan was non-inferior to ramipril and better tolerated in the prevention of cardiovascular events
Background and Objectives: Results of the recently published ONTARGET study (The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial) showed that telmisartan (80 mg/day) was non-inferior to ramipril (10 mg/ day) in reducing cardiovascular events. Clinicians in Asia doubt...
Published in: | PLoS ONE |
---|---|
Main Author: | Dans A.L.; Teo K.; Gao P.; Chen J.-H.; Jae-Hyung K.; Yusoff K.; Chaithiraphan S.; Zhu J.; Lisheng L.; Yusuf S. |
Format: | Article |
Language: | English |
Published: |
2010
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650969240&doi=10.1371%2fjournal.pone.0013694&partnerID=40&md5=7ad888439ab40ca8371492005fdb0613 |
Similar Items
-
Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)
by: Mancia G.; Schumacher H.; Redon J.; Verdecchia P.; Schmieder R.; Jennings G.; Yusoff K.; Ryden L.; Liu G.L.; Teo K.; Sleight P.; Yusuf S.
Published: (2011) -
A fuzzy rule-based Fuzzy Inferior Ratio method with reliability factor
by: Zailani N.A.M.; Ahmad S.A.S.; Mohamad D.
Published: (2021) -
The derived subgroup of the second Bieberbach group of dimension six with the quaternion point group of order eight
by: Rahman M.H.A.; Mohammad S.A.; Hamid M.A.
Published: (2024) -
Public trust on the integrity of Royal Malaysia Police: better or worse
by: Yahya A.H.; Khamis K.A.; Zakaria Z.
Published: (2023) -
CLOUD COMPUTING FOR BETTER CONSTRUCTION PROJECT MANAGEMENT PERFORMANCES
by: Khaderi S.S.; Raub N.F.; Shukor A.S.A.
Published: (2023)